Skip to content

Announcement of the Executive Director for Maridulu Budyari Gumal - SPHERE

I am delighted to announce that Professor Mark Parsons has been appointed as the Executive Director, Maridulu Budyari Gumal - Sydney Partnership for Health Education, Research and Enterprise (SPHERE).  He commenced in the role on 1 July 2021.

Professor Parsons is an internationally recognised Neurologist and leader in Stroke Medicine. He was appointed as SHARP Professor of Medicine and Neurology at UNSW South Western Sydney Clinical School and Liverpool Hospital in 2020. Previously, he was the Royal Melbourne Hospital Professorial Chair of Neurology at the University of Melbourne, and the Director of the Department of Neurology, Royal Melbourne Hospital. He is also a Conjoint Professor of Neurology at the University of Newcastle and a Visiting Professor at Fudan University, Shanghai. Mark was elected as a Fellow to the prestigious Australian Academy of Health and Medical Scientists (FAHMS) in 2019.

Mark is an international leader in Stroke clinical trials and brain imaging. He has considerable industry collaborations and serves on international and national advisory boards for several multinational companies.

Professor Parsons has an impressive history of achievement in implementing and translating his research into clinical practice change. The results of his work have led to major changes in health policy, clinical practice, and patient outcomes. His performance and success in these areas stand him in good stead for his role to strategically position SPHERE to pursue excellence in the conduct of translational research and research translation. 

Maridulu Budyari Gumal – SPHERE has achieved a great deal in its first five years. Please join me in wishing Mark every success in leading SPHERE into its second quinquennium.

Announcement of the Executive Director for Maridulu Budyari Gumal - SPHERE

I am delighted to announce that Professor Mark Parsons has been appointed as the Executive Director, Maridulu Budyari Gumal - Sydney Partnership for Health Education, Research and Enterprise (SPHERE).  He commenced in the role on 1 July 2021.

Funding success for the Maridulu Budyari Gumal - SPHERE Cancer Clinical Academic Group

The NSW Government through the Cancer Institute NSW has awarded SPHERE's Professor Geoff Delaney a $7M Translational Cancer Research Capacity Building Grant to build capacity and education across the SPHERE Cancer Clinical Academic Group. Commencing on 1 July, the 5 year program will enhance the volume of cancer research the CAG produces, but also to accelerate research translation; ensure succession planning by enhancing career development opportunities; and continue to stimulate high-quality, multidisciplinary, multi-institutional, innovative, impactful research.

Female Health Researchers Receive Financial Support to Advance Careers

Female researchers from across Australia working in women’s health research and translation have been provided financial support in a bid to facilitate the career advancement and development of women in early and mid-career stages of their research careers.